A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Effect of Intravenous Methylprednisolone on the Signs & Symptoms of Graves' Ophthalmopathy
Open Journal of Endocrine and Metabolic Diseases
Graves' ophthalmopathy (GO) is the most frequent extrathyroidal manifestation of Graves' disease (GD). The effect of intravenous methylprednisolone on the signs and symptoms of GO has not been evaluated in the Bangladeshi population. Objective: To observe the effect of intravenous methylprednisolone in active Graves' ophthalmopathy. Materials/Methods: This prospective study conducted in a tertiary hospital of Bangladesh from May 2009 to November 2010 included 30 patients having moderate todoi:10.4236/ojemd.2019.99010 fatcat:owq6pr44krbyndwqqql4d6aiva